CaniLeish

Withdrawn

This medicine's authorisation has been withdrawn

Leishmania infantum excreted secreted proteins

MedicineVeterinaryWithdrawn

Romanian is available via eTranslation, the European Commission's machine translation service.

Translate to Romanian | Important information about machine translation

Application under evaluation
CVMP opinion
European Commission decision

Overview

The marketing authorisation for this product has been withdrawn.

CaniLeish : EPAR - Summary for the public

English (EN) (97.39 KB - PDF)

Prima publicare: 06/04/2011 Cea mai recent: 24/10/2023

Alte limbi (21)

Product information

CaniLeish : EPAR - Product Information

English (EN) (807.96 KB - PDF)

Prima publicare: 06/04/2011 Cea mai recent: 24/10/2023

Alte limbi (24)

CaniLeish : EPAR - All Authorised presentations

English (EN) (58.49 KB - PDF)

Prima publicare: 06/04/2011 Cea mai recent: 24/10/2023

Alte limbi (23)

Product details

Name of medicine: CaniLeish
Active substance: Leishmania infantum excreted secreted proteins
International non-proprietary name (INN) or common name: Leishmania infantum excreted secreted proteins
Anatomical therapeutic chemical veterinary (ATCvet) code: QI07AO

Pharmacotherapeutic group

Immunologicals

Authorisation details

EMA product number: EMEA/V/C/002232

Assessment history

CaniLeish : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (137.21 KB - PDF)

Prima publicare: 21/01/2013 Cea mai recent: 24/10/2023

CaniLeish : EPAR - Public assessment report

English (EN) (730.18 KB - PDF)

Prima publicare: 06/04/2011 Cea mai recent: 24/10/2023

CVMP summary of positive opinion for Canileish

Adopted Reference Number: EMA/CVMP/296014/2010

English (EN) (80.53 KB - PDF)

Prima publicare: 14/01/2011 Cea mai recent: 24/10/2023

News on CaniLeish

This page was last updated on 24/10/2023